- Record: found
- Abstract: not found
- Article: not found
A Pilot Study of Lis-Dexamfetamine Dimesylate (LDX/SPD489) to Facilitate Smoking Cessation in Nicotine-Dependent Adults With ADHD
Scott H. Kollins ,
Joseph S. English ,
Nilda Itchon-Ramos ,
Allan K. Chrisman ,
Rachel Dew ,
Benjamin O’Brien ,
F. Joseph McClernon
May 24 2012
April 16 2012
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The goal of this study was to assess the efficacy and tolerability of lis-dexamfetamine
dimesylate (LDX) as an adjunct to nicotine replacement therapy in adult smokers with
ADHD who were undergoing a quit attempt.